메뉴 건너뛰기
Clinical Infectious Diseases
Volumn 50, Issue 2, 2010, Pages 192-193
Conjugate Meningococcal vaccines: Lifesaving or inefficient use or both-no easy answer
Author keywords

[No Author keywords available]
Indexed keywords

MENINGOCOCCUS VACCINE;
EID: 73649089685     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649210     Document Type: Note
Times cited : (2)
References (9)
  • 1
    • 73649112805 scopus 로고    scopus 로고
    • Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: Implications for prevention of meningococcal disease
    • in this issue
    • Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010;50:184-191 (in this issue).
    • (2010) Clin Infect Dis , vol.50 , pp. 184-191
    • Cohn, A.C.1    MacNeil, J.R.2    Harrison, L.H.3
  • 2
    • 20144369356 scopus 로고    scopus 로고
    • Epidemiology of nasopharyngeal carriage oí Neisseria meningitidis in healthy Dutch children
    • Bogaert D, Hermans PW, Boelens H, et al. Epidemiology of nasopharyngeal carriage oí Neisseria meningitidis in healthy Dutch children. Clin Infect Dis 2005;40:899-902.
    • (2005) Clin Infect Dis , vol.40 , pp. 899-902
    • Bogaert, D.1    Hermans, P.W.2    Boelens, H.3
  • 3
    • 17044431681 scopus 로고    scopus 로고
    • Genetic analysis of meningococci carried by children and young adults
    • Claus H, Maiden MC, Wilson DJ, et al. Genetic analysis of meningococci carried by children and young adults. J Infect Dis 2005; 191:1263-1271
    • (2005) J Infect Dis , vol.191 , pp. 1263-1271
    • Claus, H.1    Maiden, M.C.2    Wilson, D.J.3
  • 4
    • 34547669075 scopus 로고    scopus 로고
    • Health Protection Agency Centre for Infections, London, England: Health Protection Agency Centre for Infections, May
    • Health Protection Agency Centre for Infections. Protecting the health of England's children: the benefit of vaccines. London, England: Health Protection Agency Centre for Infections, May 2005:47-51.
    • (2005) Protecting the Health of England's Children: the Benefit of Vaccines , pp. 47-51
  • 5
    • 33644840604 scopus 로고    scopus 로고
    • Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands
    • DOI 10.1097/01.inf.0000195594.41449.c6, PII 0000645420060100000019
    • de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 2006;25:79-80. (Pubitemid 43361483)
    • (2006) Pediatric Infectious Disease Journal , vol.25 , Issue.1 , pp. 79-80
    • De Greeff, S.C.1    De Melker, H.E.2    Spanjaard, L.3    Schouls, L.M.4    Van Derende, A.5
  • 6
    • 33645212649 scopus 로고    scopus 로고
    • Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: A model-based evaluation
    • De Wals P, Trottier P, Pépin J. Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation. Vaccine 2006; 24:3500-3504
    • (2006) Vaccine , vol.24 , pp. 3500-3504
    • De Wals, P.1    Trottier, P.2    Pépin, J.3
  • 7
    • 61349145533 scopus 로고    scopus 로고
    • Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
    • Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol 2009;9:213-220
    • (2009) Nat Rev Immunol , vol.9 , pp. 213-220
    • Pollard, A.J.1    Perrett, K.P.2    Beverley, P.C.3
  • 8
    • 70350776511 scopus 로고    scopus 로고
    • Cost-effectiveness of pneumococcal conjugate vaccine: An update after 7 years of use in the United States
    • Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States. Vaccine 2009; 27: 6483-6494
    • (2009) Vaccine , vol.27 , pp. 6483-6494
    • Ray, G.T.1    Pelton, S.I.2    Klugman, K.P.3    Strutton, D.R.4    Moore, M.R.5
  • 9
    • 0345012052 scopus 로고    scopus 로고
    • The meningococcal vaccine - Public policy and individual choices
    • DOI 10.1056/NEJMsb035678
    • Offit PA, Peter G. The meningococcal vaccine: public policy and individual choices. N Engl J Med 2003; 349:2353. (Pubitemid 37509744)
    • (2003) New England Journal of Medicine , vol.349 , Issue.24 , pp. 2353-2356
    • Offit, P.A.1    Peter, G.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.